MiR-30e在心血管疾病中的研究进展
Research Progress of MiR-30e in Cardiovascular Disease
摘要: 根据美国心脏病协会(American Heart Association on Heart Disease and Stroke)的数据统计。全球范围内每年大约有1730万人死于心血管疾病及相关并发症,并且这个数字还在逐年增加。miRNA的发现和研究为诊断和治疗心血管疾病(cardiovascular disease, CVD)提供了新的思路。目前已知的人类miRNA有3000个以上,最初的分析推测其可调控人类至少三分之一的编码基因。也就是说miRNA为多种疾病的诊断、治疗及预后提供了潜在靶点。MicroRNAs (miRNAs)是由RNA聚合酶II (Pol II)转录的初级miRNA (primiRNA)产生的约22个核苷酸的小RNA家族。Mir-30家族是miRNA家族中的一个重要成员,由Mir-30a、Mir-30b、Mir-30c、Mir-30d和Mir-30e组成,Mir-30c又分为Mir-30c-1和Mir-30c-2,由位于人类染色体1、6和8的6个基因编码。
Abstract: According to the American Heart Association, Globally, approximately 17.3 million people die from cardiovascular disease and related complications each year, and this number is increasing every year. miRNA discovery and research provide new ideas for the diagnosis and treatment of cardio-vascular disease (CVD). There are currently more than 3000 known human miRNAs, and initial analyses have hypothesized that they regulate at least one-third of the genes encoded in humans. This means that miRNAs provide potential targets for the diagnosis, treatment and prognosis of a variety of diseases. microRNAs (miRNAs) are small RNA families of approximately 22 nucleotides produced by primary miRNAs (primiRNAs) transcribed by RNA polymerase II (Pol II). The Mir-30 family is an important member of the miRNA The Mir-30 family is an important member of the miRNA family, consisting of Mir-30a, Mir-30b, Mir-30c, Mir-30d, and Mir-30e, with Mir-30 30c is di-vided into Mir-30c-1 and Mir-30c-2, which are encoded by six genes located on human chromo-somes 1, 6 and 8.
文章引用:王胜, 李飞. MiR-30e在心血管疾病中的研究进展[J]. 临床医学进展, 2023, 13(7): 11884-11888. https://doi.org/10.12677/ACM.2023.1371665

参考文献

[1] 陈琴花. Syndecan4调控生理性心肌肥大机制研究[D]: [博士学位论文]. 南京: 南京大学, 2019.
[2] Oldfield, C.J., Duhamel, T.A. and Dhalla, N.S. (2020) Mechanisms for the Transition from Physiological to Pathological Cardiac Hy-pertrophy. Canadian Journal of Physiology and Pharmacology, 98, 74-84. [Google Scholar] [CrossRef] [PubMed]
[3] 李青, 胡斌, 牛鑫, 等. MiR-30e调控心肌肥厚的作用机制研究[J]. 现代生物医学进展, 2013, 13(20): 3804-3806+3813.
[4] Li, Q., Song, X.W., Zou, J., et al. (2010) Attenuation of mi-croRNA-1 Derepresses the Cytoskeleton Regulatory Protein Twinfilin-1 to Provoke Cardiac Hypertrophy. Journal of Cell Science, 123, 2444-2452. [Google Scholar] [CrossRef] [PubMed]
[5] 王微微. 长链非编码RNA Kcnq1ot1作为miR-30e-5p分子海绵通过调控ADAM9表达来调控心肌肥厚[D]: [硕士学位论文]. 沈阳: 中国医科大学, 2021.
[6] Wang, W., Wu, C., Ren, L., et al. (2020) MiR-30e-5p Is Sponged by Kcnq1ot1 and Represses Angiotensin II-Induced Hypertrophic Phenotypes in Cardiomyocytes by Targeting ADAM9. Experimental Cell Research, 394, Article ID: 112140. [Google Scholar] [CrossRef] [PubMed]
[7] Hunter, J.J. (1999) Signaling Pathways for Cardiac Hypertrophy and Failure. The New England Journal of Medicine, 341, 1276-1283. [Google Scholar] [CrossRef
[8] 刘永国, 任澎. 心肌缺血/再灌注损伤的机制研究进展[J]. 医学综述, 2010, 16(21): 3267-3269.
[9] Cheng, N., Li, L., Wu, Y., et al. (2021) microRNA-30e Up-Regulation Alle-viates Myocardial Ischemia-Reperfusion Injury and Promotes Ventricular Remodeling via SOX9 Repression. Molecular Immunology, 130, 96-103. [Google Scholar] [CrossRef] [PubMed]
[10] Jayasankar, V., Woo, Y.J., Pirolli, T.J., Bish, L.T. and Berry, M.F. (2005) Induction of Angiogenesis and Inhibition of Apoptosis by Hepatocyte Growth Factor Effectively Treats Postischemic Heart Failure. Journal of Cardiac Surgery, 20, 93-101. [Google Scholar] [CrossRef] [PubMed]
[11] Su, B., Wang, X., Sun, Y., et al. (2020) miR-30e-3p Promotes Cardiomyocyte Autophagy and Inhibits Apoptosis via Regulating Egr-1 during Ischemia/Hypoxia. BioMed Research International, 2020, Article ID: 7231243. [Google Scholar] [CrossRef] [PubMed]
[12] Wang, X.T., Wu, X.D., Lu, Y.X., et al. (2017) Potential Involvement of MiR-30e-3p in Myocardial Injury Induced by Coronary Microembolization via Autophagy Activation. Cellular Physiol-ogy and Biochemistry, 44, 1995-2004. [Google Scholar] [CrossRef] [PubMed]
[13] Mo, B., Wu, X., Wang, X., et al. (2019) miR-30e-5p Mitigates Hypox-ia-Induced Apoptosis in Human Stem Cell-De- rived Cardiomyocytes by Suppressing Bim. International Journal of Bi-ological Sciences, 15, 1042-1051. [Google Scholar] [CrossRef] [PubMed]
[14] Chen, Y., Yin, Y. and Jiang, H. (2021) miR-30e-5p Alleviates Inflamma-tion and Cardiac Dysfunction after Myocardial Infarction through Targeting PTEN. Inflammation, 44, 769-779. [Google Scholar] [CrossRef] [PubMed]
[15] Pu, L.M., Kong, X.Y., Li, H. and He, X. (2021) Exosomes Re-leased from Mesenchymal Stem Cells Overexpressing microRNA-30e Ameliorate Heart Failure in Rats with Myocardial Infarction. American Journal of Translational Research, 13, 4007-4025.
[16] Marques, F.Z., Vizi, D., Khammy, O., et al. (2016) The Transcardiac Gradient of Cardio-microRNAs in the Failing Heart. European Journal of Heart Failure, 18, 1000-1008. [Google Scholar] [CrossRef] [PubMed]
[17] Ovchinnikova, E.S., Schmitter, D., Vegter, E.L., et al. (2016) Signature of Circulating microRNAs in Patients with Acute Heart Failure. European Journal of Heart Failure, 18, 414-423. [Google Scholar] [CrossRef] [PubMed]
[18] 徐晓飞. 无创呼吸机治疗急性心力衰竭的疗效观察[J]. 中华全科医学, 2016, 14(10): 1669-1670+1728. [Google Scholar] [CrossRef
[19] 方圻, 王士雯, 宁田海, 等. 充血性心力衰竭诊断和治疗对策[J]. 中华心血管病杂志, 1995(2): 83-94.